145
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Chemosensitizing Effect of Saikosaponin B on B16F10 Melanoma Cells

, , &
Pages 505-511 | Received 23 Oct 2015, Accepted 02 Dec 2016, Published online: 17 Feb 2017

References

  • Holohan C, Van Schaeybroeck S, Longley DB, and Johnston PG: Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10), 714–726, 2013.
  • Longley DB and Johnston PG: Molecular mechanisms of drug resistance. J Pathol 205(2), 275–292, 2005.
  • Gottesman MM: Mechanisms of cancer drug resistance. Annu Rev Med 53, 615–627, 2002.
  • Ben-Neriah Y and Karin M: Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12(8), 715–723, 2011.
  • Das KC and White CW: Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. J Biol Chem 272(23), 14914–14920, 1997.
  • Campbell KJ, Rocha S, and Perkins ND: Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13(6), 853–865, 2004.
  • Nakanishi C and Toi M: Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5(4), 297–309, 2005.
  • Qi F, Li A, Inagaki Y, Gao J, Li J, et al.: Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 4(6), 297–307, 2010.
  • Zhu J, Luo C, Wang P, He Q, Zhou J, et al.: Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-kappaB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med 5(5), 1345–1350, 2013.
  • Wang Q, Zheng XL, Yang L, Shi F, Gao LB, et al.: Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res 29, 159, 2010.
  • Takahashi K, Takeda K, Saiki I, Irimura T, and Hayakawa Y: Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-kappaB pathway to induce metastatic potential. Cancer Sci 104(5), 558–562, 2013.
  • Lou C, Takahashi K, Irimura T, Saiki I, and Hayakawa Y: Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-kappaB activation. Int J Oncol 45(5), 2085–2091, 2014.
  • Kwon O, Kim KA, Kim SO, Ha R, Oh WK, et al.: NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. Carcinogenesis 27(11), 2258–2268, 2006.
  • Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, et al.: Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol Ther 11(7), 678–689, 2011.
  • Kingma PS and Osheroff N: Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanism. J Biol Chem 273(29), 17999–18002, 1998.
  • Burma S, Chen BP, Murphy M, Kurimasa A, and Chen DJ: ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276(45), 42462–42467, 2001.
  • Bao Y, Li C, Shen H, and Nan F: Determination of saikosaponin derivatives in Radix bupleuri and in pharmaceuticals of the chinese multiherb remedy xiaochaihu-tang using liquid chromatographic tandem mass spectrometry. Anal Chem 76(14), 4208–4216, 2004.
  • Vyas D, Laput G, and Vyas AK: Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther 7, 1015–1023, 2014.
  • Schwartz SA, Hernandez A, and Mark Evers B: The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies. Surg Oncol 8(3), 143–153, 1999.
  • Pommier Y, Sordet O, Antony S, Hayward RL, and Kohn KW: Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23(16), 2934–2949, 2004.
  • Karin M, Cao Y, Greten FR, and Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2(4), 301–310, 2002.
  • Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, et al.: Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22(21), 3243–3251, 2003.
  • Sun Y, Cai TT, Zhou XB, and Xu Q: Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. Int Immunopharmacol 9(7–8), 978–983, 2009.
  • Leung CY, Liu L, Wong RN, Zeng YY, Li M, et al.: Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun 338(4), 1920–1927, 2005.
  • Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, et al.: Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 46(4), 605–611, 1994.
  • Zhang D, Yang R, Wang S, and Dong Z: Paclitaxel: new uses for an old drug. Drug Des Devel Ther 8, 279–284, 2014.
  • Filgueiras Mde C, Morrot A, Soares PM, Costa ML, and Mermelstein C: Effects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cells. PLoS One 8(4), e63177, 2013.
  • Zong Z, Fujikawa-Yamamoto K, Tanino M, Teraoka K, Yamagishi H, et al.: Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochem Biophys Res Commun 219(2), 480–485, 1996.
  • Lin TY, Chiou CY, and Chiou SJ: Putative genes involved in saikosaponin biosynthesis in bupleurum species. Int J Mol Sci 14(6), 12806–12826, 2013.
  • Nose M, Amagaya S, and Ogihara Y: Corticosterone secretion-inducing activity of saikosaponin metabolites formed in the alimentary tract. Chem Pharm Bull (Tokyo) 37(10), 2736–2740, 1989.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.